Interim Results

RNS Number : 0202A
Nanoco Group PLC
26 March 2012
 



 

A briefing for analysts will be held at 10am this morning, 26 March 2012, at the offices

of Buchanan, 107 Cheapside, London EC2V 6DN

 

 

For immediate release

 

26 March 2012

 

NANOCO GROUP PLC

("Nanoco" or "the Company")

 

Interim results for the six months ended 31 January 2012 

 

 

Nanoco Group plc (AIM: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials, is pleased to announce its interim results for the six months ended 31 January 2012.

 

Highlights in the period to date

 

·      US$1m milestone payment for achieving specification targets for green quantum dots including a 50,000 hour performance life

 

·      Joint development agreement signed with one of the world's largest lighting companies for use of Nanoco quantum dots in general lighting

 

·      Further agreement signed with Tokyo Electron in the next phase of development of a nanomaterial-based solar film

 

·      Joint development agreement signed with major Asian electronics company for the use of Nanoco quantum dots in the LED backlighting of LCD displays

 

·      Manufacturing scale-up continued with planning permission granted for the Kilo Lab facility at Runcorn

 

·      Cash, cash equivalents and deposits as at 31 January 2012 of £14.4 million (31 July 2011: £17.1 million)

 

 

Commenting on the results, Dr Peter Rowley, Nanoco's Chairman, said:

 

"Our transition from a research-based company to a commercially focused, high-tech manufacturing business continues apace. Our existing commercial agreements are proceeding well and we continue in discussions with further potential customers. We are now working to deliver a 1kg batch of green quantum dots to a Japanese customer, attracting a US$2 million milestone payment."

 

 

For further information please contact:

 

Nanoco

+ 44 (0) 161 603 7900

Michael Edelman, Chief Executive Officer


Colin White, Chief Financial Officer




Bank of America Merrill Lynch - Joint Broker

+ 44 (0) 20 7996 2490

Will Smith                                            

                         



Canaccord Genuity - Nomad and Joint Broker

                           +44 (0) 20 7050 6500

Simon Bridges


Cameron Duncan




Buchanan

+ 44 (0) 20 7466 5000

Mark Court / Jessica Fontaine


 



 

 

Notes for editors:

 

About Nanoco Group plc

Nanoco is a world leader in the development and manufacture of commercial quantities of quantum dots for use in multiple applications including lighting, solar cells and biological imaging.Nanoco's quantum dots, which are free of heavy metals and comply with RoHS legislation, can be combined into a wide range of materials including liquids, polymers and glass. Nanoco forms strategic partnerships with major end users across a range of applications.

 

Nanoco was founded in 2001 and is based in Manchester, UK. Nanoco began trading on the AIM market of the London Stock Exchange in May 2009 under the ticker symbol NANO.



 

 

Chairman's and Chief Executive Officer's Joint Review

 

         

Overview

 

During the six months to 31 January 2012 we continued with our transition from a research-based company to a high-tech manufacturing business capable of producing commercial quantities of cadmium-free quantum dots (CFQD™), which are free of any heavy metals and do not use rare earth elements, for multiple customer applications. We made progress in all of the key areas of our business including commercial relationships, company infrastructure, manufacturing scale-up and protection of our growing intellectual property estate.

 

A particular highlight of the period was signing our first commercial relationship in general lighting. This relationship, with one of the world's largest lighting companies, is focused on combining Nanoco's quantum dots with LEDs to create LEDs with optimal colour characteristics for general use, such as in homes and offices. The relationship is also significant in that it marks the Company's first major agreement to be signed in the USA.

 

Another key highlight during the period was receiving the US$1 million milestone payment from a Japanese customer for achieving the customer's performance criteria for green quantum dots, including a service life of at least 50,000 hours.

 

The bespoke green quantum dots are designed for use with LEDs for backlighting LCD displays and for solid-state lighting in the home.   The 50,000 hour service life, which is equivalent to almost six years of non-stop use, gives an indication of the potential of LEDs - such lighting units would consume less electricity than traditional lighting and the units would rarely need to be replaced.

 

Whilst the advantages of LEDs over traditional lighting - including long service life, reduced power consumption, compact size and shock resistance - have been recognised for some time, the widespread adoption of LEDs has been limited by their colour performance. LEDs tend to produce a rather harsh, bluish white light which is unsuited to an office or home environment. Nanoco's quantum dots have been shown to overcome this limitation, creating a major opportunity for the Company.

 

We have made good progress across all of our commercial collaborations and we were pleased to announce a follow-on agreement with Tokyo Electron, the Japanese equipment supplier for whom we are developing a nanomaterial-based solar ink. In addition, and just two weeks after the period end, we announced a new collaboration with a major electronics company in Asia, to use our quantum dots in backlighting for LCD TVs, in a country outside of Japan.

 

Our business development activities are currently focused on Japan, the USA, Korea and Taiwan. In these regions, we are in discussions with multiple potential customers predominantly in our core areas of LED backlighting, LED general lighting and solar power.

 

We are also in discussions with customers in relation to new uses of our quantum dots in a wide variety of applications. At the current time, we are being careful to remain focused on our core areas whilst being alert to new opportunities.

 

We continued the development of our company infrastructure during the period and, to accommodate our increasing level of activity, we signed a lease to a further 12,500 square feet of laboratory space at our Manchester head office. We also received outline planning permission for the Kilo Lab production facility in Runcorn, on which detailed design work is currently being completed. The start of construction of the Kilo Lab facility will be timed to reflect our order book and will take approximately 18 months to build and commission. Plans are also in place, once commercial agreements have been signed, to add additional capacity through the expansion of the existing lines from 25kg to 40kg and by adding further 40kg lines within the existing space.

 

The Nanoco team currently comprises 62 staff, most of whom are highly qualified scientists. During the six months to 31 January 2012 we recruited four new technical staff.

 

 

Commercial contracts

 

Our commercial contracts have progressed well.

 

In our supply and licence agreement with a major Japanese corporation, we were focused during the period on successfully achieving the corporation's performance criteria for green quantum dots. As announced on 31 January 2012, we achieved this milestone, triggering a US$1 million payment from the customer.

 

We are currently producing a 1kg batch of the green quantum dots, which, once produced and validated by the customer, will attract a US$2 million payment. It is expected that the 1kg of green quantum dots will be delivered during the current half year.

 

In April last year, Nanoco received a US$2 million payment from the corporation for 1kg of red quantum dots. This was a major technical breakthrough, and a world first in that quantum dots had never before been manufactured in this batch size.

 

The intention of this major Japanese corporation is to combine the bespoke red and green quantum dots with blue LEDs to produce a highly efficient source of white light for multiple applications, for use in both general lighting and in backlighting LCD displays.

 

We have made significant progress with one of the world's largest lighting companies in producing a high quality, low cost product for the general lighting market.  The potential size of the general LED lighting market is very exciting. We believe that this market potential will be significantly enhanced by the incorporation of our quantum dots into LED lights making quality of light on a par with alternative, higher energy usage products.

 

Our development work, under an agreement with a major Japanese electronics company, on quantum dot based backlights for LCD TVs is continuing.  We are currently working with our partner to determine the optimum method to physically integrate our quantum dots into their displays with the least disruption to their existing manufacturing process while gaining the optimum optical performance.  While it is difficult to predict the exact timing and scale of orders, our current analysis suggests commercial shipments of materials for this application will commence in 2013.

 

There is considerable interest in the use of quantum dots in LCD TVs because they have the potential to offer the improved colour performance equal to that of organic light-emitting diode (OLED) technology. Display makers, which have already invested in substantial LCD manufacturing capacity, are keen to be able to improve the quality of the displays manufactured using their existing LCD manufacturing lines.

 

In the first two weeks of the current half, we were delighted to announce a new joint development agreement with a major electronics company in Asia. The agreement is in connection with the use of our quantum dots in the electronics company's display products. The global electronics company is based outside of Japan and therefore increases the number of countries in which we have contractual agreements.

 

Our development work with Tokyo Electron, the major Japanese equipment supplier, to create a bespoke solar ink using cadmium-free nanoparticles is proceeding well. In October 2011, we were delighted to sign a further agreement with Tokyo Electron under which we are focusing on further improving the performance of the photovoltaic ink in terms of its efficiency of electrical conversion, its cost and its ease of printing.

 

 

Scaling up production

 

Our production facility at The Heath Technology Park in Runcorn comprises two fully commissioned Semi-Tech lines with the capacity to produce around 25kg of quantum dots annually. We are currently using the lines to produce the 1kg batch of green quantum dots for the major Japanese corporation referred to above.

 

The next stage of the scale-up plan is the installation of Kilo Lab equipment, which would increase total capacity to around 150 to 200kg annually. We received outline planning permission for the Kilo Lab facility, which would be constructed at The Heath Technology Park, in December 2011 and are currently finalising the detailed design. As previously stated, it is intended to begin construction only when justified by visibility in our order book.

 

 

Financial results

 

Revenues in the six months to 31 January 2012 were £1.32 million (H1 2011: £1.14 million) and the loss before tax was £2.36 million (H1 2011: loss of £1.65 million). At this stage in the Company's development, revenues are primarily a reflection of the amount and timing of milestone and joint development payments from strategic partners.

 

Cost of sales increased over the prior year period partly as a consequence of the increase in joint development programmes. Administrative expenses have increased as a consequence, primarily, of:  new technical staff in support of the joint development projects, higher patent related costs, costs of designing the Kilo Lab and the additional costs associated with the Semi-Tech plant at Runcorn, which was commissioned in January 2011.

 

Statutory cash, cash equivalents and deposits, at 31 January 2012 were £14.4 million (31 January 2011: £3.8 million; 31 July 2011: £17.1 million). Both cash and costs continue to be prudently and tightly managed.

 

 

 

Outlook

 

Our transition from a research-based company to a commercially focused, high-tech manufacturing business continues apace. Our existing commercial agreements are proceeding well and we continue in discussions with further potential customers. We are now working to deliver a 1kg batch of green quantum dots for a Japanese customer, attracting a US$2 million milestone payment.

 

While it is difficult to predict the exact timing and scale of orders, we continue to expect that commercial production will commence during the 2012/13 year and look forward to the future with confidence.

 

 

 

 

 

 

Peter Rowley                                                                            Michael Edelman

Non-Executive Chairman                                                          Chief Executive Officer

26 March 2012                                                                           26 March 2012

 



Consolidated Statement of Comprehensive Income

For the six months ended 31 January 2012

 



Six months to

31 January 2012

Six months to

31 January 2011

 Year to

31 July

2011



(Unaudited)

(Unaudited)

(Audited)



£'000

£'000

£'000


Notes









Revenue

2

1,321

1,140

2,642






Cost of sales


(597)

(475)

(1,085)






Gross profit


724

665

1,557






Administrative expenses


(3,242)

(2,335)

(4,942)











Operating loss


 

- before share-based payment


(2,363)

(1,566)

(3,232)

- share-based payment


(155)

(104)

(153)



(2,518)

(1,670)

(3,385)






Finance income


158

28

180

Finance costs


(4)

(5)

(10)






Loss on ordinary activities before taxation


(2,364)

(1,647)

(3,215)






Taxation

3

343

271

723






Loss for the period and total comprehensive loss for the period


(2,021)

(1,376)

(2,492)











Loss per share :





Basic loss for the period

4

(1.00)p

(0.75)p

(1.30)p
















 



Consolidated Statement of Changes in Equity

For the six months ended 31 January 2012

 





Share-





Issued

based





equity

payment

Merger

Revenue

Total


capital

reserve

reserve

reserve

equity


£'000

£'000

£'000

£'000

£'000







At 1 August 2010

12,351

333

(1,242)

(3,588)

7,854







Loss for the six months to 31 January 2011

-

-

-

(1,376)

(1,376)

Issue of share capital

290

-

-

-

290

Share-based payments

-

104

-

-

104







At 31 January 2011

12,641

437

(1,242)

(4,964)

6,872







Loss for the six months to 31 July 2011

-

-

-

(1,116)

(1,116)

Issue of share capital

15,305

-

-

(432)

14,873

Expenses of placing

(519)


-

-

(519)

Share-based payments

-

49

-

-

49







At 31 July 2011

27,427

486

(1,242)

(6,512)

20,159







Loss for the six months to 31 January 2012

-

-

-

(2,021)

(2,021)

Issue of share capital

53

-

-

-

53

Expenses on issue of shares

(10)

-

-

-

(10)

Share-based payments

-

155

-

-

155







At 31 January 2012

27,470

641

(1,242)

(8,533)

18,336

 



Statement of Financial Position

As at 31 January 2012

 


 

 

31 January 2012

 

31 January 2011

31 July  2011


(Unaudited)

(Unaudited)

(Audited)


£'000

£'000

£'000





Assets




Non-current assets




Tangible fixed assets

2,804

3,244

3,153

Intangible assets

949

692

828






3,753

3,936

3,981

Current assets

Inventories

 

67

 

42

 

80

Trade and other receivables

1,451

386

407

Income tax asset

924

685

581

Short-term investments and cash on deposit

9,838

-

12,015

Cash and cash equivalents

4,558

3,793

5,084






16,838

4,906

18,167

Total assets

20,591

8,842

22,148

 

Liabilities




Current liabilities




Trade and other payables

1,939

1,461

1,641

Financial liabilities

63

63

63






2,002

1,524

1,704





Non-current liabilities




Financial liabilities

253

317

285

Deferred tax liability

-

129

-






253

446

285

Total liabilities

2,255

1,970

1,989

Net assets

18,336

6,872

20,159









Capital and reserves




Issued equity capital

27,470

12,641

27,427

Share-based payment reserve

                     641

             437

486

Merger reserve

(1,242)

(1,242)

(1,242)

Revenue reserve

(8,533)

(4,964)

(6,512)





Total equity

18,336

6,872

20,159

 

Approved by the Board and authorised for issue on 26 March 2012

 

 

 

Colin White

Director   



Cash Flow Statement

For the six months ended 31 January 2012

 


Six months to

31 January 2012

(Unaudited)

Six months to

31 January 2011

(Unaudited)

Year to

31 July 2011

(Audited)


£'000

£'000

£'000





Loss before interest and tax

(2,518)

(1,670)

(3,385)

Adjustments for:




Depreciation of tangible fixed assets

423

289

734

Amortisation of intangible assets

58

41

87

Share-based payments

155

104

153

Changes in working capital :




Decrease/(increase) in inventories

13

(24)

(62)

(Increase)/decrease in trade and other receivables

(1,044)

198

279

Increase/(decrease) in trade and other payables

298

(349)

352

Cash outflow from operating activities

(2,615)

(1,411)

(1,842)

Interest paid

(4)

(5)

(10)

Research and development tax credit received

-

87

514

Net cash outflow from operating activities

(2,619)

(1,329)

(1,338)





Cash flows from investing activities:




Purchases of tangible fixed assets

(74)

(730)

(1,605)

Purchases of intangible fixed assets

(179)

(117)

(299)

Decrease (increase) in cash placed on deposit

2,177

2,000

(10,015)

Interest received

158

28

78





Net cash inflow (outflow) from investing activities

2,082

1,181

(11,841)





Cash flows  from financing activities:




Net proceeds from the issue of ordinary share capital

53

290

15,163

Expenses on issue of shares

(10)

-

(519)

Loan repayment

(32)

(31)

(63)

Net cash inflow from financing activities

11

259

14,581





(Decrease)/increase in cash and cash equivalents

(526)

111

1,402

Cash and cash equivalents at the start of the period

5,084

3,682

3,682

Cash and cash equivalents at the end of the period

4,558

3,793

5,084

Monies placed on deposit

9,838

-

12,015

Cash, cash equivalents and deposits at the end of the period

14,396

3,793

17,099

 



Notes to the Interim Financial Report

For the six months ended 31 January 2012

 

1.   Accounting policies

 

Basis of preparation

The accounting policies adopted in this interim financial report are consistent with those followed in the preparation of the Group's annual report and accounts for the year to 31 July 2011.  The interim financial information for the six months ended 31 January 2012 and 31 January 2011 is unaudited and does not constitute statutory accounts as defined in the Companies Act 2006.  This interim financial report includes audited comparatives for the year to 31 July 2011.  The 2011 annual report and accounts received an unqualified audit opinion and has been filed with the Registrar of Companies. This interim financial report has been prepared in accordance with International Financial Reporting Standards (IFRS) as adopted by the European Union and has been prepared under the historical cost convention.

 

Basis of consolidation

This interim financial report consolidates the financial statements of Nanoco Group PLC and the entities it controls (its subsidiaries).

 

2.   Segmental information

        

         Operating segments

       The Group operates as one business segment, providing high performance nano-particles for research and development purposes.  This is the level at which operating results are reviewed by the chief operating decision maker (i.e. the CEO) to make decisions about resources, and for which financial information is available. All revenues have been generated from continuing operations and are from external customers.

      

      


Six months to

31 January  2012

Six months to

31 January 2011

Year to 

31 July 2011


£'000

£'000

£'000

Analysis of revenue




Products sold

101

71

194

Rendering of services

728

748

1,351

Royalties and licences

492

321

1,097


1,321

1,140

2,642

 

      

Geographical information

The Group operates in four main geographic areas, although all are managed from the UK.  The Group's revenue per geographical segment is as follows:

 


Six months to

31 January  2012

Six months to

31 January 2011

Year to 

31 July 2011


£'000

£'000

£'000

Analysis of revenue




UK

94

-

-

Europe (excluding UK)

96

92

200

Asia

1,086

1,048

2,397

USA

45

-

45


1,321

1,140

2,642

 

All the Group's assets are held in the UK and all of its capital expenditure arises in the UK.

 

 

3.   Tax

 

The tax credit of £343,000 recorded in the consolidated statement of comprehensive income for the six months ended 31 January 2012 (£271,000 for the six months ended 31 January 2011) is in respect of a research and development tax credit receivable. The tax credit of £723,000 for the year ended 31 July 2011 is in respect of a research and development tax credit receivable of £594,000 and a deferred taxation charge reversal of £129,000. 

 

 

4.   Loss per share

 


31 January

 2012

31 January

2011

31 July 

2011


£'000

£'000

£'000

Loss for the financial period

  attributable to equity shareholders

(2,021)

(1,376)

(2,492)

Share-based payments

155

104

153

Loss for the financial period   before share-based payments

(1,866)

(1,272)

(2,339)

Weighted average number of shares:

No.

No.

No.

Ordinary shares in issue

202,199,473

183,137,569

192,142,536

Adjusted loss per share before share-based payments (pence) 

(0.92)p

(0.69)p

(1.22)p

Basic loss per share (pence)

(1.00)p

(0.75)p

(1.30)p

 

Diluted loss per share has not been presented above as the effect of share options issued is anti-dilutive.

 

 

5.   Interim financial report

 

A copy of this interim financial report will be distributed to shareholders and is also available on the Company's website at www.nanocotechnologies.com.

 

 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR UVSKRUSAOUAR
UK 100

Latest directors dealings